Alpine Immune Sciences, Inc.
CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

Last updated:

Abstract:

Provided herein are variant CTLA-4 polypeptides and immunomodulatory proteins and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of disease applications, including for treatment of autoimmune or inflammatory conditions. Compositions and methods for making and using such proteins are provided.

Status:
Application
Type:

Utility

Filling date:

9 Oct 2018

Issue date:

1 Oct 2020